Military forces have faced the potential of crippling radiation exposure for decades, first during the Cold War and recently with “dirty bombs” emerging as a potential terrorist weapon. Antidotes for radiation sickness exist, but work is ongoing to develop more effective treatments that increase survival rates. The U.S. Defense Advanced Research Projects Agency (Darpa) last month announced encouraging findings from work in this area, some of which resulted from the Radiation Biodosimetry ...
THIS CONTENT REQUIRES SUBSCRIPTION ACCESS
You must have an Aviation Week Intelligence Network (AWIN) account or subscribe to this Market Briefing to access "Radiation Shield".
Current Aviation Week Intelligence Network (AWIN) enterprise and individual members: please go to http://awin.aviationweek.com for access.
Not currently a subscriber? Click on the "Learn More" button below to view subscription offers.